Skip to main content
Clinical Trials/NCT04065373
NCT04065373
Completed
Not Applicable

ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues

ivWatch, LLC1 site in 1 country45 target enrollmentApril 25, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infiltration of Peripheral IV Therapy
Sponsor
ivWatch, LLC
Enrollment
45
Locations
1
Primary Endpoint
Normal Tissue Red Notification Rate
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A single arm study of 40 adult volunteers to assess the safety and efficacy of the ivWatch SmartTouch and fiber optic sensors when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.

Registry
clinicaltrials.gov
Start Date
April 25, 2019
End Date
June 21, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed consent
  • Pass health screen
  • 18 years or older

Exclusion Criteria

  • Fail health screen

Outcomes

Primary Outcomes

Normal Tissue Red Notification Rate

Time Frame: 24 Hours

The ivWatch Model 400 issues red notifications to communicate the need for a clinician to check an IV site. A red notification suggests an increased likelihood that an IV infiltration may be occurring, with a greater likelihood relative to a yellow notification. This measure describes the average number of red notifications issued by the ivWatch device in a given day when monitoring normal, non-infiltrated tissues. The 95% confidence interval for the red notification rate was calculated using a negative binomial regression model.

Secondary Outcomes

  • Normal Tissue Yellow Notification Rate(24 Hours)
  • Significant Skin Irritation or Disruption to Skin Integrity(24 Hours)

Study Sites (1)

Loading locations...

Similar Trials